Noticias de EXEL_US

Noticias del mercado

Últimas noticias sobre EXEL_US — 379 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: EXEL_US ✕ 379 resultados
17/04/2026 EXEL_US — Yahoo Finance
Assessing Exelixis (EXEL) Valuation After Recent Short Term Share Price Pressure
16/04/2026 EXEL_US — Seeking Alpha
Exelixis: The Double Backbone Potential Of CABOMETYX And Zanzalintinib (NASDAQ:EXEL)
16/04/2026 EXEL_US — Yahoo Finance
Will Exelixis (EXEL) Beat Estimates Again in Its Next Earnings Report?
16/04/2026 EXEL_US — Quiver Quantitative
EXEL | Exelixis Inc Executive Compensation
15/04/2026 EXEL_US — Quiver Quantitative
EXELIXIS, INC. ($EXEL) CEO 2025 Pay Revealed | EXEL Stock News
15/04/2026 EXEL_US — Quiver Quantitative
EXELIXIS, INC. ($EXEL) CEO 2025 Pay Revealed | EXEL Stock News
15/04/2026 EXEL_US — Stock Titan
Executive pay and equity plan on ballot at Exelixis (NASDAQ: EXEL) 2026 meeting
15/04/2026 EXEL_US — Seeking Alpha
Exelixis: Stable Demand And High Margins With Undervalued Shares (NASDAQ:EXEL)
15/04/2026 EXEL_US — Yahoo Finance
Here's Why Exelixis (EXEL) is a Strong Momentum Stock
14/04/2026 EXEL_US — Markets Mojo
Exelixis, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Indicators
03/04/2026 EXEL_US — Yahoo Finance
Exelixis (EXEL) is a Top-Ranked Value Stock: Should You Buy?
03/04/2026 EXEL_US — tayninh.gov.vn
EXEL Stock Analysis: Exelixis Inc. Minor Daily Dip and $44 Support Assessment
01/04/2026 EXEL_US — Eastern Progress ES ← EN
Exelixis publica resultados preliminares del 25 y publica perspectivas del 26
31/03/2026 EXEL_US — Yahoo Finance
Kidney Cancer Drugs Market to Grow by $2 Billion During 2026-2030: Pfizer, Novartis, Exelixis, Roche, Bristol Myers Squibb Company, and Bayer Lead the Industry
31/03/2026 EXEL_US — ChartMill
Exelixis Inc. (NASDAQ:EXEL) Presents a Compelling Value Investment Case
28/03/2026 EXEL_US — MSN ES ← EN
RBC Capital reduce el precio objetivo de Exelixis (EXEL) a 43 dólares
28/03/2026 EXEL_US — MSN
RBC Capital lowers Exelixis (EXEL) price target to $43
28/03/2026 EXEL_US — Yahoo Finance
RBC Capital Lowers Exelixis (EXEL) Price Target to $43
26/03/2026 EXEL_US — Stock Titan
Vanguard disaggregates holdings; Exelixis (NASDAQ: EXEL) shows 0 shares

Página 19 de 19

keyboard_arrow_up